全文获取类型
收费全文 | 26636篇 |
免费 | 2520篇 |
国内免费 | 2027篇 |
专业分类
耳鼻咽喉 | 304篇 |
儿科学 | 239篇 |
妇产科学 | 276篇 |
基础医学 | 2976篇 |
口腔科学 | 354篇 |
临床医学 | 3322篇 |
内科学 | 3467篇 |
皮肤病学 | 220篇 |
神经病学 | 1431篇 |
特种医学 | 912篇 |
外国民族医学 | 9篇 |
外科学 | 3083篇 |
综合类 | 5483篇 |
现状与发展 | 4篇 |
预防医学 | 1746篇 |
眼科学 | 722篇 |
药学 | 3109篇 |
19篇 | |
中国医学 | 1618篇 |
肿瘤学 | 1889篇 |
出版年
2024年 | 21篇 |
2023年 | 327篇 |
2022年 | 608篇 |
2021年 | 1029篇 |
2020年 | 906篇 |
2019年 | 784篇 |
2018年 | 786篇 |
2017年 | 765篇 |
2016年 | 737篇 |
2015年 | 1146篇 |
2014年 | 1377篇 |
2013年 | 1403篇 |
2012年 | 2159篇 |
2011年 | 2002篇 |
2010年 | 1486篇 |
2009年 | 1215篇 |
2008年 | 1438篇 |
2007年 | 1538篇 |
2006年 | 1553篇 |
2005年 | 1485篇 |
2004年 | 1169篇 |
2003年 | 1271篇 |
2002年 | 1080篇 |
2001年 | 902篇 |
2000年 | 780篇 |
1999年 | 694篇 |
1998年 | 346篇 |
1997年 | 387篇 |
1996年 | 268篇 |
1995年 | 275篇 |
1994年 | 212篇 |
1993年 | 144篇 |
1992年 | 158篇 |
1991年 | 138篇 |
1990年 | 140篇 |
1989年 | 103篇 |
1988年 | 83篇 |
1987年 | 86篇 |
1986年 | 57篇 |
1985年 | 49篇 |
1984年 | 22篇 |
1983年 | 19篇 |
1982年 | 6篇 |
1981年 | 14篇 |
1980年 | 5篇 |
1979年 | 2篇 |
1974年 | 2篇 |
1965年 | 1篇 |
1954年 | 1篇 |
1932年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
随着人口老龄化进程的加速,脑小血管病(CSVD)的发病率也在不断上升,其导致的多种症状严重影响了患者的生活质量。MRI弥散张量成像(DTI)作为新近发展的影像技术,有无创显示白质纤维超微结构等优点,已被广泛用于疾病早期诊断、病情预测、治疗评估等多方面的研究。本文即就DTI技术在CSVD中的研究现状和未来发展前景进行综述。 相似文献
32.
Yang Luan Yan Zhang Kai Cui Fan Li Baolong Qin Yajun Ruan Kun Tang Hongyang Jiang Hao Li Xiaoyi Yuan Zhuo Liu Xiaming Liu Gan Yu Shengfei Xu Ruibao Chen Huan Yang Xiaolin Guo Xiaoyong Zeng Zhong Chen Zhiqiang Chen Zhiquan Hu Xiaodong Song Zhihua Wang Shaogang Wang Jihong Liu Tao Wang 《Translational andrology and urology》2021,10(1):466
BackgroundTo introduce and determine the value of optimized strategies for the management of urological tube-related emergencies with increased incidence, complexity and operational risk during the global spread of coronavirus disease 2019 (COVID-19).MethodsAll emergent urological patients at Tongji Hospital, Wuhan, during the period of January 23 (the beginning of lockdown in Wuhan) to March 23, 2020, and the corresponding period in 2019 were recruited to form this study’s COVID-19 group and control group, respectively. Tongji Hospital has the most concentrated and strongest Chinese medical teams to treat the largest number of severe COVID-19 patients. Patients in the control group were routinely treated, while patients in the COVID-19 group were managed following the optimized principles and strategies. The case incidence for each type of tube-related emergency was recorded. Baseline characteristics and management outcomes (surgery time, secondary complex operation rate, readmission rate, COVID-19 infection rate) were analyzed and compared across the control and COVID-19 periods.ResultsThe total emergent urological patients during the COVID-19 period was 42, whereas during the control period, it was 124. The incidence of tube-related emergencies increased from 53% to 88% (P<0.001) during the COVID-19 period. In particular, the incidence of nephrostomy tube-related (31% vs. 15%, P=0.027) and single-J stent-related problems (19% vs. 6%, P=0.009) increased significantly. The mean surgery times across the two periods were comparable. The number of secondary complex operations increased from 12 (18%) to 14 (38%) (P=0.028) during the COVID 19-period. The number of 2-week postoperative readmission decreased from 10 (15%) to 1 (3%) (P=0.049). No participants contracted during the COVID-19 period.ConclusionsUrological tube-related emergencies have been found to have a higher incidence and require more complicated and dangerous operations during the COVID-19 pandemic. However, the optimized management strategies introduced in this study are efficient, and safe for both urologists and patients. 相似文献
33.
34.
放疗是治疗胰腺癌的重要手段。但受胰腺运动等因素影响,放疗疗效难以充分发挥。更高效的胰腺癌放疗有赖于运动管理方式的改进与高质量的图像引导。新兴的MR引导放疗技术软组织分辨率高、无额外辐射、能进行功能成像,经过大量研究评估与验证,其在靶区与危及器官的精准勾画、辅助运动管理和自适应放疗等方面有着巨大优势,有望更好地发挥放疗在胰腺癌治疗中的作用。本文就MR引导放疗在胰腺癌治疗中的应用作一综述和展望。 相似文献
35.
Jim Zhong Michael Gallagher Chris Hounslow Gareth Iball Tze Wah 《Diagnostic and interventional radiology (Ankara, Turkey)》2021,27(2):244
PURPOSEWe aimed to evaluate the effect on the radiation dose to the patient by reducing the tube current during the placement of the ablation needles (reduced dose group) compared with the patient doses delivered when scanning at the standard fully diagnostic level (full dose group) in computed tomography (CT)-guided percutaneous cryoablation.METHODSWe conducted a retrospective study of 103 patients undergoing cryoablation in a tertiary cancer center. Overall, 62 patients were scanned with standard exposure parameters (full dose group) set on a 64-slice multidetector CT scanner, while 41 patients were scanned on a reduced dose protocol. Dose levels were retrieved from the hospital picture and archiving communication system including the volumetric CT dose index (CTDIvol), total dose length product (DLP), length of cryoablation procedure, number of cryoablation needles and patient size. Wilcoxon Mann-Whitney (rank-sum) tests were used to compare the median DLP, CTDIvol and skin dose between the two groups.RESULTSMedian total DLP for the full dose group was 6025 mGy·cm (1909–13353 mGy·cm) compared with 3391 mGy·cm (1683–6820 mGy·cm) for the reduced dose group. The reduced dose group had a 44% reduction in total DLP and 42% reduction in total CTDIvol (p < 0.001). The estimated skin doses were 384 mGy for the full dose group and 224 mGy for the reduced dose group (42% reduction) (p < 0.001). At 12-month follow-up, the technical success for the full dose (n=62) was 97% with 2 patients requiring a further cryoablation treatment for residual tumor. The technical success for the reduced dose group (n=41) was 100%.CONCLUSIONCT dose reduction technique during image-guided cryoablation treatment of renal tumors can achieve significant radiation dose reduction whilst maintaining sufficient image quality.Renal cell carcinoma is the most common kidney cancer and has a rising incidence (1–4), with obesity and smoking being major risk factors (5–8).Image-guided ablation offers a more minimally invasive option compared with surgery and the current evidence base shows that it is a safe and effective treatment for T1a tumors, with a low rate of complications (9–11). The major advantage of cryoablation over other modalities is the ability to accurately visualize the iceball and therefore zone of ablation on intraprocedural imaging, either with computed tomography (CT) or magnetic resonance imaging (MRI) (12, 13). However, renal cryoablation involves the placement of more ablation probes and can have almost three times the radiation exposure compared with CT-guided radiofrequency ablation procedures (14).In addition to this substantial radiation dose per cryoablation, estimated to be between 32 and 39.7 mSv, the follow-up CT imaging will also add to the total radiation burden (15, 16). Whilst this level of radiation dose and associated stochastic risk may be a lesser concern in the older patients, greater consideration needs to be given to younger patients (<50 years old) and in patients requiring lifelong follow-up imaging, in particular those with hereditary diseases such as Von Hippel-Lindau syndrome (15). To our knowledge, the potential for reducing radiation dose for cryoablation patients.The principle aim of this study was to evaluate the effect on the radiation dose to the patient by reducing the tube current during the placement of the ablation needles (reduced dose group) compared with the patient doses delivered when scanning at the standard fully diagnostic level (full dose group) in CT-guided percutaneous cryoablation. 相似文献
36.
37.
38.
39.
40.
目的采用网络药理学方法寻找黄连阿胶汤的有效成分、治疗靶标。方法根据药代动力学参数筛选药物成分,通过网络药理学方法挖掘药物和疾病靶标并构建药物-靶点网络,研究黄连阿胶汤成分的作用机制。结果发现黄连阿胶汤中的氢化小檗碱、β-谷甾醇、山姜素、山柰酚、小檗浸碱、荠苎黄酮等19个成分可能通过调控5-羟色胺、多巴胺、γ氨基丁酸、阿片受体、乙酰胆碱等25个靶点作用于失眠症治疗。结论黄连阿胶汤可能主要通过多个靶点调控多种神经递质发挥对失眠症的治疗作用。 相似文献